Terms: = Breast cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
254 results:
1. Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer.
Li Y; Yang X; Geng C; Liu Y; Tang T; Zhang L; Liu F; Zhang M; Hao J; Ma L
Front Immunol; 2024; 15():1390261. PubMed ID: 38726001
[TBL] [Abstract] [Full Text] [Related]
2. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract] [Full Text] [Related]
3. Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.
Yu X; He Z; Wang Z; Ke S; Wang H; Wang Q; Li S
Exp Cell Res; 2024 May; 438(2):114053. PubMed ID: 38663476
[TBL] [Abstract] [Full Text] [Related]
4. PDP1 promotes the progression of breast cancer through STAT3 pathway.
Wang Y; Dang H; Qiao H; Tian Y; Guan Q
Cell Biochem Funct; 2024 Apr; 42(3):e3994. PubMed ID: 38566355
[TBL] [Abstract] [Full Text] [Related]
5. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway.
Guo M; Liu M; Li W; Wang C; Zhang L; Zhang H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):155. PubMed ID: 38526702
[TBL] [Abstract] [Full Text] [Related]
6. Correlation between S100A7 and immune characteristics, methylation, tumor stemness and tumor heterogeneity in pan-cancer and its role in chemotherapy resistance in breast cancer.
Li Y; Yang X; Jin T; Li Q; Li X; Ma L
Aging (Albany NY); 2024 Mar; 16(6):5581-5600. PubMed ID: 38499391
[TBL] [Abstract] [Full Text] [Related]
7. Moracin D suppresses cell growth and induces apoptosis via targeting the XIAP/PARP1 axis in pancreatic cancer.
Zhong X; Ke X; Yang H; Ye X; Li C; Pan J; Ran W; Wang F; Cui H
Phytomedicine; 2024 Jun; 128():155527. PubMed ID: 38489888
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
9. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative breast cancer by Activating Notch Signaling.
Li B; Huang L; Ruan J
Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
[TBL] [Abstract] [Full Text] [Related]
10. The novel circRNA circ_0045881 inhibits cell proliferation and invasion by targeting mir-214-3p in triple-negative breast cancer.
Ren J; Chen W; Zhou Y; Sun J; Jiang G
BMC Cancer; 2024 Mar; 24(1):278. PubMed ID: 38429642
[TBL] [Abstract] [Full Text] [Related]
11. Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced breast cancer Receiving Palbociclib: Results From the TREnd Trial.
Migliaccio I; Romagnoli D; Galardi F; De Luca F; Biagioni C; Curigliano G; Criscitiello C; Minisini AM; Moretti E; Risi E; Guarducci C; Nardone A; Biganzoli L; Benelli M; Malorni L
JCO Precis Oncol; 2024 Feb; 8():e2300285. PubMed ID: 38427931
[TBL] [Abstract] [Full Text] [Related]
12. The small nucleolar RNA SNORA51 enhances breast cancer stem cell-like properties via the RPL3/NPM1/c-MYC pathway.
Li S; Jin Z; Song X; Ma J; Peng Z; Yu H; Song J; Zhang Y; Sun X; He M; Yu X; Jin F; Zheng A
Mol Carcinog; 2024 Jun; 63(6):1117-1132. PubMed ID: 38421204
[TBL] [Abstract] [Full Text] [Related]
13. sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
14. RNF213 inhibits migration in lung adenocarcinoma cell.
Liu X; Zeng H; Li Z; Wei C; Zhang Z; Liu X; Chen N
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):286-292. PubMed ID: 38279417
[TBL] [Abstract] [Full Text] [Related]
15. Bioinformatic analysis reveals an association between Metadherin with breast cancer prognosis and tumor immune infiltration.
Yang L; Yang L; Kong F; Zhang S; Pu P; Li X; Song Z
Sci Rep; 2024 Jan; 14(1):1949. PubMed ID: 38253625
[TBL] [Abstract] [Full Text] [Related]
16. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
Fang Y; Zhang Q; Chen Z; Guo C; Wu J
Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic value of stem cell markers in triple-negative breast cancer.
Almási S; Nagy Á; Krenács T; Lantos T; Zombori T; Cserni G
Pathol Oncol Res; 2023; 29():1611365. PubMed ID: 38188613
[TBL] [Abstract] [Full Text] [Related]
18. SLC35A2 expression drives breast cancer progression via ERK pathway activation.
Yang X; Tao Y; Xu Y; Cai W; Shao Q
FEBS J; 2024 Apr; 291(7):1483-1505. PubMed ID: 38143314
[TBL] [Abstract] [Full Text] [Related]
19. Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway.
Chang Y; Jia HQ; Xu B; Yang L; Xu YT; Zhang JY; Wang MQ; Yang LX; Song ZC
Chem Biol Drug Des; 2024 Jan; 103(1):e14416. PubMed ID: 38093418
[TBL] [Abstract] [Full Text] [Related]
20. Alcohol dehydrogenase-1B represses the proliferation, invasion and migration of breast cancer cells by inactivating the mitogen-activated protein kinase signalling pathway.
Jiang C; Liu R; Wu X
J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085522
[TBL] [Abstract] [Full Text] [Related]
[Next]
